POLR3A
protein-codingRNA polymerase III subunit A, the group of RNA polymerase subunits
Gene summary
The protein encoded by this gene is the catalytic component of RNA polymerase III, which synthesizes small RNAs. The encoded protein also acts as a sensor to detect foreign DNA and trigger an innate immune response. [provided by RefSeq, Aug 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~76.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0700276
Submitter: ClinGen
The association of POLR3A variants with autosomal recessive tremor-ataxia with central hypomyelination (TACH), leukodystrophy with oligodontia (LO), and hypomyelination, hypodontia and hypogonadotropic hypogonadism (4H) syndrome was first described in 2011 (Bernard, et al. 2011, PMID: 21855841). Variants were then described in association with Wiedemann-Rautenstrauch syndrome (WRS) (PMID: 30414627) in 2018. Per criteria outlined by the Clingen Lumping and Splitting Working Group, we found no difference in molecular mechanism(s) or inheritance pattern; and found that the spectrum of phenotypic variability could exist between the described disease entities. Therefore, the prior disease entities have been lumped into one entity, POLR3A-Related Disorders (MONDO:0700276). Clinical characteristics include a variable age of onset with a spectrum of global developmental delay, failure to thrive, hypomyelinating leukodystrophy, neurological dysfunction, dental abnormalities, and hypogonadotropic hypogonadism. POLR3A is the largest subunit of RNA Polymerase III, which transcribes ribosomal, transfer, and nuclear RNAs (PMID: 34395528). Included in this curation are twelve unique variants found in nine subjects across four publications. Four of the twelve variants are predicted or proven null variants (canonical splice site variants or nonsense), the remainder are missense variants. Four of the variants had functional data supporting pathogenicity of the variant (PMID: 21855841, PMID: 30898877, PMID:38561452). Two variants had points upgraded due to variant recurrence across non-related affected patients. The mechanism of function is loss-of-function. Gene-disease relationship is supported by mouse models with POLR3A mutations (PMID: 38168294, PMID: 34583988). The gene-disease pair has had replication over time showing convincing evidence. More evidence in the literature is present, but the maximum score required for genetic evidence has been reached (12 points). To summarize, there is definitive evidence supporting the relationship between POLR3A and POLR3A-Related Disorders, with rigorous and reproducible evidence in clinical and research settings. This gene-disease curation based on ClinGen criteria was approved by the Leukodystrophy and Leukoencephalopathy GCEP on 8/28/2024 (SOP version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0700276
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0005608
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011897
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009910
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019177
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0009910
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018655
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019177
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011897
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019505
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018656
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009910
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dental; Endocrine; Musculoskeletal; Neurologic; Pulmonary
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POLR3A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007055.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 15 | 297 | 5 | 318 | |
| missense | 3 | 48 | 422 | 12 | 485 | |
| nonsense | 22 | 19 | 1 | 42 | ||
| start loss | 2 | 2 | ||||
| frameshift | 20 | 18 | 2 | 40 | ||
| splice donor/acceptor (+/-2bp) | 3 | 31 | 6 | 40 | ||
| Total | 48 | 119 | 446 | 309 | 5 | 927 |
Highest pathogenic variant AF is 0.0024086204
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008986.2 | 31 | MANE Select | |
| Ensembl | ENSP00000361446.3 | 31 | MANE Select | |
| Ensembl | ENSP00000473389.1 | 6 | Standard | |
| Ensembl | ENSP00000513898.1 | 30 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pyrimidine metabolism - Homo sapiens (human)
- Cytosolic DNA-sensing pathway - Homo sapiens (human)
- RNA polymerase - Homo sapiens (human)
- Purine metabolism - Homo sapiens (human)
- Epstein-Barr virus infection - Homo sapiens (human)
Biological Process
- transcription, DNA-templated
- transcription by RNA polymerase III
- positive regulation of interferon-beta production
- innate immune response
- defense response to virus
Molecular Function
- RNA polymerase III activity
- DNA binding
- chromatin binding
- DNA-directed 5'-3' RNA polymerase activity
- metal ion binding
Cellular Component
- nucleoplasm
- RNA polymerase III complex
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000372371
- Coding exons
- 31
- Length
- 54397
- Individuals with no LoFs
- 125603
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 145
- Defined
- 125748
- p
- 0.000577
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.31 | 574 | 752 | 0.763 | 0.0000442 | 9159 |
| Missense (PolyPhen) | 120 | 246.3 | 0.48721 | 2910 | ||
| Synonymous | 0.527 | 283 | 295 | 0.961 | 0.0000189 | 2689 |
| Loss of Function | 2.40 | 47 | 68.4 | 0.687 | 0.00000402 | 835 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00062 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00082 | 0.00082 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00070 | 0.00069 | rare |
| South Asian | 0.00085 | 0.00085 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic core component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Forms the polymerase active center together with the second largest subunit. A single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol III. A bridging helix emanates from RPC1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol III by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition (By similarity). Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway. {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- LoFtool
- 0.761
- RVIS EVS
- -1.92
- RVIS percentile EVS
- 1.93
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 1.00
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |